1. Anti-infection Apoptosis
  2. Fungal Parasite Apoptosis
  3. Justicidin B

Justicidin B is a potent anticancer lignan and proapoptotic agent. Justicidin B is also a bone resorption inhibitor, and has strong antiviral, fungicidal, antiprotozoal effects. Justicidin B significantly inhibits platelet aggregation.

For research use only. We do not sell to patients.

Justicidin B Chemical Structure

Justicidin B Chemical Structure

CAS No. : 17951-19-8

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg   Get quote  
50 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Justicidin B is a potent anticancer lignan and proapoptotic agent. Justicidin B is also a bone resorption inhibitor, and has strong antiviral, fungicidal, antiprotozoal effects. Justicidin B significantly inhibits platelet aggregation[1][2][3].

IC50 & Target

Trypanosoma

 

Cellular Effect
Cell Line Type Value Description References
A2058 IC50
8.9 μM
Compound: 2
Cytotoxicity against human A2058 cells incubated for 24 hrs by AlamarBlue staining based analysis
Cytotoxicity against human A2058 cells incubated for 24 hrs by AlamarBlue staining based analysis
[PMID: 36857518]
A549 IC50
11.4 μM
Compound: 2
Cytotoxicity against human A549 cells incubated for 24 hrs by AlamarBlue staining based analysis
Cytotoxicity against human A549 cells incubated for 24 hrs by AlamarBlue staining based analysis
[PMID: 36857518]
BGC-823 IC50
0.18 μM
Compound: 2
Cytotoxicity against human BGC-823 cells assessed as reduction in cell viability measured after 4 days by MTT colorimetric assay
Cytotoxicity against human BGC-823 cells assessed as reduction in cell viability measured after 4 days by MTT colorimetric assay
[PMID: 36857518]
Calu-1 IC50
18.5 μM
Compound: 2
Cytotoxicity against human Calu-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
Cytotoxicity against human Calu-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
[PMID: 36857518]
EBC-1 IC50
63.2 μM
Compound: 2
Cytotoxicity against human EBC-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
Cytotoxicity against human EBC-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
[PMID: 36857518]
HepG2 IC50
16.8 μM
Compound: 2
Cytotoxicity against human HepG2 cells incubated for 24 hrs by AlamarBlue staining based analysis
Cytotoxicity against human HepG2 cells incubated for 24 hrs by AlamarBlue staining based analysis
[PMID: 36857518]
HT-29 IC50
5.9 μM
Compound: 2
Cytotoxicity against human HT-29 cells incubated for 24 hrs by AlamarBlue staining based analysis
Cytotoxicity against human HT-29 cells incubated for 24 hrs by AlamarBlue staining based analysis
[PMID: 36857518]
MONO-MAC-6 IC50
2.5 μM
Compound: 2
Cytotoxicity against human MONO-MAC-6 cells incubated for 24 hrs by AlamarBlue staining based analysis
Cytotoxicity against human MONO-MAC-6 cells incubated for 24 hrs by AlamarBlue staining based analysis
[PMID: 36857518]
NCI-H838 IC50
11 μM
Compound: 2
Cytotoxicity against human NCI-H838 cells incubated for 24 hrs by AlamarBlue staining based analysis
Cytotoxicity against human NCI-H838 cells incubated for 24 hrs by AlamarBlue staining based analysis
[PMID: 36857518]
PC-3 IC50
5.7 μM
Compound: 2
Cytotoxicity against human PC-3 cells incubated for 24 hrs by AlamarBlue staining based analysis
Cytotoxicity against human PC-3 cells incubated for 24 hrs by AlamarBlue staining based analysis
[PMID: 36857518]
RPMI-8226 IC50
0.17 μM
Compound: 2
Cytotoxicity against human RPMI-8226 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against human RPMI-8226 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
[PMID: 36857518]
U-87MG ATCC IC50
21.6 μM
Compound: 2
Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis
Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis
[PMID: 36857518]
In Vitro

Justicidin B inhibits the growth of the pathogenic fungi Aspergillus fumigatus (MIC ≥ 1 μg/mL), Aspergillus flavus (MIC ≥ 12 μg/mL), and Candida albicans (MIC ≥ 4 μg/mL), but is not effective against Cryptococcus neoformans and Blastoschizomyces capitatus[1].
Justicidin B also exhibits strong activity against the trypomastigote form of Trypanosoma brucei rhodesiense (IC50 = 0.2 μg/mL) and moderate activity against Trypanosoma cruzi (IC500 = 2.6 μg/mL)[1].
Justicidin B shows cytotoxic activity and induction of apoptosis in MDA-MB-231 and MCF-7 breast cancer derived cell lines. The 24 h treatment of both cell lines increased the level of apoptotic DNA fragmentation. Exposure of MDA-MB-231 cells with Justicidin B leads to concentration dependent decrease in the expression of NFkB; whereas the treatment of MCF-7, is consistent with strong increase in the expression of this transcription factor[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

364.35

Formula

C21H16O6

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

O=C1OCC2=CC3=CC(OC)=C(OC)C=C3C(C4=CC=C(OCO5)C5=C4)=C12

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : 12.5 mg/mL (34.31 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.7446 mL 13.7231 mL 27.4461 mL
5 mM 0.5489 mL 2.7446 mL 5.4892 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 1.25 mg/mL (3.43 mM); Clear solution

    This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% Corn Oil

    Solubility: ≥ 1.25 mg/mL (3.43 mM); Clear solution

    This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: ≥99.0%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.7446 mL 13.7231 mL 27.4461 mL 68.6153 mL
5 mM 0.5489 mL 2.7446 mL 5.4892 mL 13.7231 mL
10 mM 0.2745 mL 1.3723 mL 2.7446 mL 6.8615 mL
15 mM 0.1830 mL 0.9149 mL 1.8297 mL 4.5744 mL
20 mM 0.1372 mL 0.6862 mL 1.3723 mL 3.4308 mL
25 mM 0.1098 mL 0.5489 mL 1.0978 mL 2.7446 mL
30 mM 0.0915 mL 0.4574 mL 0.9149 mL 2.2872 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Justicidin B
Cat. No.:
HY-114275
Quantity:
MCE Japan Authorized Agent: